4.7 Article

A Description of Acute Renal Failure and Nephrolithiasis Associated With Sodium-Glucose Co-Transporter 2 Inhibitor Use: A VigiBase Study

Related references

Note: Only part of the references are listed.
Article Urology & Nephrology

Drug-Induced Acute Kidney Injury

Mark A. Perazella et al.

Summary: Medications can cause acute kidney injury (AKI) through direct tubular injury, induction of inflammation, and crystalline deposition. Clinicians should understand the pathogenesis of these forms of kidney injury for prevention and treatment.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)

Article Urology & Nephrology

Network Meta-Analysis of Novel Glucose-Lowering Drugs on Risk of Acute Kidney Injury

Min Zhao et al.

Summary: The study compared the effects of DPP-4 inhibitors, GLP-1RAs, and SGLT2 inhibitors on AKI risk using network meta-analysis. Results showed that SGLT2 inhibitors had a lower risk of AKI compared to DPP-4 inhibitors and GLP-1RAs, with SGLT2 inhibitors having the highest probability of being the safest intervention. This suggests that SGLT2 inhibitors may be a preferred treatment option for reducing AKI risk.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Article Urology & Nephrology

Risk of UTI in kidney stone formers: a matched-cohort study over a median follow-up of 19 years

Eleanor Brain et al.

Summary: The study found that kidney stone formers are at significantly increased risk of developing urinary tract infections, highlighting the importance of monitoring and prevention in this population.

WORLD JOURNAL OF UROLOGY (2021)

Article Endocrinology & Metabolism

Sodium-glucose cotransporter 2 inhibitors and risk of nephrolithiasis

Kasper B. Kristensen et al.

Summary: Initiation of treatment with SGLT2Is was associated with a clinically significant reduced risk of incident and recurrent nephrolithiasis.

DIABETOLOGIA (2021)

Article Gastroenterology & Hepatology

Diabetes mellitus is a risk factor of acute kidney injury in liver transplantation patients

Yu-Jia Wang et al.

Summary: Diabetes is an independent risk factor for AKI after orthotopic LT, and AKI is associated with delayed graft function recovery and higher mortality in the short-term postoperative period. Diabetic patients who develop AKI after LT experience a faster decline of eGFR within the first year after surgery.

HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2021)

Letter Medicine, General & Internal

Empagliflozin-induced severe osmotic nephrosis and acute renal injury in advanced chronic kidney disease

Charmaine Si Min Sia et al.

ANNALS ACADEMY OF MEDICINE SINGAPORE (2021)

Article Public, Environmental & Occupational Health

An investigation on the association between sodium glucose co-transporter 2 inhibitors use and acute pancreatitis: A VigiBase study

Ioana Frent et al.

Summary: This study analyzed acute pancreatitis reports related to SGLT2 inhibitors in a global pharmacovigilance database, and found a significant association between canagliflozin, empagliflozin, and dapagliflozin use and pancreatitis. The majority of cases had favorable outcomes.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2021)

Article Urology & Nephrology

Osmotic Nephrosis and Acute Kidney Injury Associated With SGLT2 Inhibitor Use: A Case Report

Gautam Phadke et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2020)

Editorial Material Urology & Nephrology

We Can Finally Stop Worrying About SGLT2 Inhibitors and Acute Kidney Injury

Vikas S. Sridhar et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2020)

Review Cardiac & Cardiovascular Systems

Renoprotection with SGLT2 inhibitors in type 2 diabetes over a spectrum of cardiovascular and renal risk

Francesco Giorgino et al.

CARDIOVASCULAR DIABETOLOGY (2020)

Article Endocrinology & Metabolism

Nephrolithiasis and sodium-glucose co-transporter-2 (SGLT-2) inhibitors: A meta-analysis of randomized controlled trials

Claudia Cosentino et al.

DIABETES RESEARCH AND CLINICAL PRACTICE (2019)

Article Physiology

SGLT2 inhibition and renal urate excretion: role of luminal glucose, GLUT9, and URAT1

Aleksandra Novikov et al.

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2019)

Review Public, Environmental & Occupational Health

Body fatness, diabetes, physical activity and risk of kidney stones: a systematic review and meta-analysis of cohort studies

Dagfinn Aune et al.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2018)

Review Endocrinology & Metabolism

Benefits of SGLT2 Inhibitors Beyond Glycemic Control - A Focus on Metabolic, Cardiovascular and Renal Outcomes

Molly G. Minze et al.

CURRENT DIABETES REVIEWS (2018)

Article Cardiac & Cardiovascular Systems

Acute renal failure with sodium-glucose-cotransporter-2 inhibitors: Analysis of the FDA adverse event report system database

A. Perlman et al.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2017)

Article Endocrinology & Metabolism

Acute Kidney Injury in Patients on SGLT2 Inhibitors: A Propensity-Matched Analysis

Girish N. Nadkarni et al.

DIABETES CARE (2017)

Article Cardiac & Cardiovascular Systems

Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus

David Z. I. Cherney et al.

CIRCULATION (2014)

Article Multidisciplinary Sciences

Incidence and Characteristics of Acute Kidney Injury in Severe Diabetic Ketoacidosis

Jean-Christophe Orban et al.

PLOS ONE (2014)

Article Public, Environmental & Occupational Health

Choosing Thresholds for Statistical Signal Detection with the Proportional Reporting Ratio

Jim Slattery et al.

DRUG SAFETY (2013)

Article Urology & Nephrology

Notice

Kidney International Supplements (2012)